NASDAQ:SGP | Free Cash Flow | SpyGlass Pharma, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2024-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$13.54M$676,000.00-$14.22M
2025-03-31-$8.2M$164,000.00-$8.37M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$32.7M$789,000.00-$33.49M
2024-12-31-$22.03M$1.99M-$24.02M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.